Pitt-Hopkins Syndrome: Clinical and Molecular Findings of a 5-Year-Old Patient

Pitt Hopkins syndrome (PTHS) is a very rare condition and until now, approximately 500 patients were reported worldwide, of which not all are genetically confirmed. Usually, individuals with variants affecting exons 1 to 5 in the TCF4 gene associate mild intellectual disability (ID), between exons 5 to 8, moderate to severe ID and sometimes have some of the characteristics of PTHS, and variants starting from exon 9 to exon 20 associate a typical PTHS phenotype. In this report, we describe the clinical and molecular findings of a Caucasian boy diagnosed with PTHS. PTHS phenotype is described including craniofacial dysmorphism with brachycephaly, biparietal narrowing, wide nasal bridge, thin and linear lateral eyebrows, palpebral edema, full cheeks, short philtrum, wide mouth with prominent and everted lips, prominent Cupid’s bow, downturned corners of the mouth, microdontia and also the clinical management of the patient. The previously and the current diagnosis scores are described in this report and also the challenges and their benefits for an accurate and early diagnosis.

[1]  M. Wegner,et al.  Transcription factor Tcf4 is the preferred heterodimerization partner for Olig2 in oligodendrocytes and required for differentiation , 2020, Nucleic acids research.

[2]  B. Puisac,et al.  Evaluating Face2Gene as a Tool to Identify Cornelia de Lange Syndrome by Facial Phenotypes , 2020, International journal of molecular sciences.

[3]  B. Peterlin,et al.  Diagnostic and Clinical Utility of Clinical Exome Sequencing in Children With Moderate and Severe Global Developmental Delay / Intellectual Disability , 2020, Journal of child neurology.

[4]  F. Tripon,et al.  Simultaneous FLT3, NPM1 and DNMT3A mutations in adult patients with acute myeloid leukemia – case study , 2019, Revista Romana de Medicina de Laborator.

[5]  Carol J. Saunders,et al.  Diagnosis and management in Pitt‐Hopkins syndrome: First international consensus statement , 2019, Clinical genetics.

[6]  P. Rakic,et al.  Disruption of TCF4 regulatory networks leads to abnormal cortical development and mental disabilities , 2019, Molecular Psychiatry.

[7]  Peter M. Krawitz,et al.  Identifying facial phenotypes of genetic disorders using deep learning , 2019, Nature Medicine.

[8]  C. Sismani,et al.  Two unrelated individuals carrying rare mosaic deletions in TCF4 gene , 2018, American journal of medical genetics. Part A.

[9]  F. Tripon,et al.  The utility of molecular genetic techniques in craniosynostosis cases associated with intellectual disability , 2018, Revista Romana de Medicina de Laborator.

[10]  F. Tripon,et al.  Multiplex ligation dependent probe amplification - A useful, fast and cost-effective method for identification of small supernumerary marker chromosome in children with developmental delay and congenital heart defect , 2018, Revista Romana de Medicina de Laborator.

[11]  Kimberly Goodspeed,et al.  Pitt-Hopkins Syndrome: A Unique Case Study , 2018, Journal of the International Neuropsychological Society.

[12]  Dandan Xin,et al.  A case of Pitt-hopkins Syndrome with de novo mutation in TCF4: Clinical features and treatment for epilepsy , 2018, International Journal of Developmental Neuroscience.

[13]  J. Mandel,et al.  Disease-causing variants in TCF4 are a frequent cause of intellectual disability: lessons from large-scale sequencing approaches in diagnosis , 2018, European Journal of Human Genetics.

[14]  C. Powell,et al.  Pitt-Hopkins Syndrome: A Review of Current Literature, Clinical Approach, and 23-Patient Case Series , 2018, Journal of child neurology.

[15]  R. Chitwood,et al.  Common Pathophysiology in Multiple Mouse Models of Pitt–Hopkins Syndrome , 2017, The Journal of Neuroscience.

[16]  E. Zackai,et al.  Impairment of different protein domains causes variable clinical presentation within Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4. , 2017, European journal of medical genetics.

[17]  Barbara N. Pusey,et al.  Complex translocation disrupting TCF4 and altering TCF4 isoform expression segregates as mild autosomal dominant intellectual disability , 2016, Orphanet Journal of Rare Diseases.

[18]  R. Hennekam,et al.  Phenotype and natural history in 101 individuals with Pitt-Hopkins syndrome through an internet questionnaire system , 2016, Orphanet Journal of Rare Diseases.

[19]  B. Maher,et al.  Neurodevelopmental models of transcription factor 4 deficiency converge on a common ion channel as a potential therapeutic target for Pitt Hopkins syndrome , 2016, Rare diseases.

[20]  M. Zollino,et al.  Pitt–Hopkins Syndrome and Differential Diagnosis: A Molecular and Clinical Challenge , 2015, Journal of Pediatric Genetics.

[21]  M. Hill,et al.  The emerging roles of TCF4 in disease and development. , 2014, Trends in molecular medicine.

[22]  A. Afenjar,et al.  Novel comprehensive diagnostic strategy in Pitt–Hopkins syndrome: Clinical score and further delineation of the TCF4 mutational spectrum , 2012, Human mutation.

[23]  J. Ignatius,et al.  Pitt-Hopkins Syndrome , 2011, Molecular Syndromology.

[24]  T. Timmusk,et al.  Functional Diversity of Human Basic Helix-Loop-Helix Transcription Factor TCF4 Isoforms Generated by Alternative 5′ Exon Usage and Splicing , 2011, PloS one.

[25]  R. Pettinato,et al.  The Pitt‐Hopkins syndrome: Report of 16 new patients and clinical diagnostic criteria , 2011, American journal of medical genetics. Part A.

[26]  N. Philip,et al.  TCF4 Deletions in Pitt‐Hopkins Syndrome , 2008, Human mutation.